Article Name North America
This first-in-human implantation highlights how purpose-built technology can transform care for our smallest patients
26th March, 2026
This expanded availability reflects MatrixCare's alignment with nVoq's proven approach to responsible AI and speech recognition
18th March, 2026
This next-generation version of EpiCapture utilises machine learning tools that integrate additional patient features, including patient ethnicity
25th March, 2026
Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient care
25th March, 2026
The Aperio GT Elite scanner establishes a new benchmark for high-throughput digital pathology research workflows
24th March, 2026
This Photosonic technology enables a more precise definition of treatment areas
24th March, 2026
Approval marks a historic milestone for Americans living with ssAR who are at high risk for surgery and previously had no dedicated transcatheter treatment option
23rd March, 2026
This collaboration is a key strategic milestone in the continued expansion of Trinity Biotech’s New York State Department of Health
23rd March, 2026
Innovative Investigational Ventricular Assist Device Marks Major Step Forward in Patient Care
18th March, 2026
High-throughput, mid-capacity LH210 expands the VISQUE DPS lineup with fast scanning, optimised data size, and scalable digital pathology workflow
18th March, 2026
Data Across 29 Presentations Highlights Precision, Accessibility and Platform-Agnostic Adoption, Establishing ALZpath’s Proprietary pTau217 as a Highly Accurate Industry Benchmark
18th March, 2026
Kavthekar is a seasoned financial executive with nearly three decades of leadership experience spanning provider-side healthcare, retail and speciality pharmacy, e-commerce, and technology
17th March, 2026
Luraco's medical massage chairs are now positioned to serve a growing role in hospitals, clinical wellness programs
16th March, 2026
Approximately 97 per cent of people diagnosed with ALS have TDP-43 pathology, making it a central biological hallmark of the disease
13th March, 2026
QuidelOrtho is strengthening its global immunoassay offering through a new partnership aimed at expanding assay availability beyond its existing VITROS diagnostic system portfolio
12th March, 2026
New platform connects devices, data and care teams across the patient journey to streamline operations and enhance outcomes for patients and staff
10th March, 2026
An AI-powered platform & virtual clinical workforce that eliminates documentation, automates care coordination, and expands rural provider capacity
10th March, 2026
First-in-class solution consolidates multiple assays into a single test, enabling broader viral detection, faster time-to-result and more confident decision-making in regulated biopharmaceutical quality control
10th March, 2026
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer